News from Zyme and the companies we work with.
SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows
Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland, 05 November 2025: SPT [...]
Optibrium Delivers Real-Time Collaboration in its Comprehensive Molecular Design Platform with StarDrop 8
Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritisation decisions CAMBRIDGE, UK, 04 November 2025 – Optibrium, a leading developer of software and AI [...]
Nuclera expands access to eProtein Discovery for APAC customers with distributor agreement in Australia and New Zealand
Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion Cambridge, UK, and Boston MA, USA, 03 November 2025: Nuclera, the biotechnology company accelerating drug discovery by [...]
VALANX Biotech appoints Klaus Orlinger, PhD. as Chief Scientific Officer
Strategic hire of industry expert bolsters leadership team as Company progresses first antibody drug conjugate to candidate selection phase Appointment will drive development of VALANX’ GoldenSite™ platform to advance development [...]
ProImmune Ltd introduces ProVE® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility
Oxford, UK – 30 October 2025 – ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class [...]
Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery
Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas for severe respiratory disease [...]
OMED Health Partners with Aviva to Support the Digestive Health of Employees
75 Aviva employees to gain pilot access to doctor-led OMED Health Plans, which include the use of the OMED Health Breath Analyzer and mobile app Collaboration will evaluate the impact [...]
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colorado — October 22, 2025 — Biodesix, Inc. (NYSE: BDSX), a leading [...]
ProImmune Expands into New 18,000 sq ft Global Headquarters Enabling Major Expansion in Immunology and Life Science Innovation
Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UK Increased operational capacity enables accelerated development of ProImmune’s REVEAL® Immunogenicity [...]
Bio-Rad’s iQ-Check Enterobacteriaceae Kit Validated for Detection of Enterobacteriaceae in Infant Formula and Cereals
Certified by MicroVal for Detection of Enterobacteriaceae Including Salmonella, Cronobacter, and E.coli as Indicator of Process Effectiveness to Eliminate Contaminants in Infant Formula and Related Ingredients. HERCULES, Calif. — October [...]
Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral
Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated for the programme are now available from Enamine’s [...]
Mosaic Therapeutics appoints Thomas Fuchs as CEO
Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadership Appointment strengthens executive leadership team and supports transition into [...]
